Mild hypomagnesemia as the most common Cisplatin nephropathy in Iran.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Iranian Journal of Kidney Diseases

• Publication date

  2013-01-13

• Fields of study

  Medicine

• Identifiers
  PMID 23314138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of alcoholic extract of Nigella sativa on cisplatin-induced toxicity in rat.

  2012cited by this paper
• Science behind cisplatin-induced nephrotoxicity in humans: a clinical study.

  2012cited by this paper
• Thoracic malignancies, cisplatin and renal function

  2011cited by this paper
• Ifosfamide nephropathy in patients with sarcoma.

  2011cited by this paper
• Evaluation of Intravenous Magnesium Supplementation as Prophylaxis for Cisplatin-induced Hypomagnesemia

  2010cited by this paper
• Cisplatin-Induced Renal Salt Wasting Syndrome

  2010cited by this paper
• Serum potassium, calcium and magnesium in patients receiving ESHAP chemotherapy for relapsed lymphomas

  2009cited by this paper
• THE EFFECTS OF HIGH DOSE METHOTREXATE IN PATIENTS WITH NEOPLASTIC DISEASES: A PROSPECTIVE STUDY

  2008cited by this paper
• Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.

  2008cited by this paper
• Differentiating appropriate antidiuretic hormone secretion, inappropriate antidiuretic hormone secretion and cerebral salt wasting: the common, uncommon, and misnamed

  2008cited by this paper
• RENAL SIDE EFFECTS OF IFOSFAMIDE IN PATIENTS ADMITTED FOR CHEMOTHERAPY

  2008cited by this paper
• Cisplatin nephropathy: is cytotoxicity avoidable?

  2007cited by this paper
• Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: A report from the late effects surveillance system

  2007cited by this paper
• Gitelman-like syndrome after cisplatin therapy: a case report and literature review

  2006cited by this paper
• Cellular processing of platinum anticancer drugs

  2005cited by this paper
• Cisplatin-associated nephrotoxicity and pathological events.

  2005cited by this paper
• Molecular mechanisms of platinum resistance: still searching for the Achilles' heel.

  2004cited by this paper
• Cisplatin nephrotoxicity.

  2003cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial

  2003cited by this paper
• Role of Apoptosis in Fibrogenesis

  2002cited by this paper
• Biochemical and molecular mechanisms of cisplatin resistance.

  2002cited by this paper
• Mechanisms of resistance to cisplatin.

  2001cited by this paper
• Cisplatin: from DNA damage to cancer chemotherapy.

  2001cited by this paper
• Cisplatin dose rate as a risk factor for nephrotoxicity in children.

  1998cited by this paper
• Cisplatin nephrotoxicity.

  1994cited by this paper
• Renal salt wasting in patients treated with cisplatin.

  1988cited by this paper
• Cisplatin nephrotoxicity: symptomatic hypomagnesemia and renal failure.

  1986cited by this paper

• Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

  2019cites this paper
• Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis

  2018cites this paper
• Protective effects of zingerone on oxidative stress and inflammation in cisplatin-induced rat nephrotoxicity.

  2018cites this paper
• Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer

  2016cites this paper
• ADDIS ABABA UNIVERSITY COLLEGE OF HEALTH SCIENCES SCHOOL OF ALLIED HEALTH SCIENCES DEPARTMENT OF MEDICAL LABORATORY SCIENCES EVALUATION OF NEPHROTOXICITY AMONG CERVICAL AND OVARIAN CANCER PATIENTS TREATED WITH CISPLASTIN BASED CHEMOTHERAPY AT TIKUR

  2016cites this paper
• Glia and glial polyamines. Role in brain function in health and disease

  2016cites this paper
• Weekly versus Three-Weekly Cisplatin-based Concurrent Chemoradiotherapy as definitive treatment in Head and Neck Cancer- Where do we stand?

  2016cites this paper
• Urine ratio of neutrophil gelatinase-associated lipocalin to creatinine as a marker for early detection of cisplatin-associated nephrotoxicity.

  2015cites this paper
• RETRACTED ARTICLE: Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors

  2015cites this paper
• Hypomagnesemia and cisplatin nephrotoxicity

  2015cites this paper
• Incidence and spectrum of electrolyte disturbances in cisplatin based chemotherapy

  2015cites this paper
• MAGNESIUM AND POTASSIUM PARENTERAL SUPPLEMENTATION DOES NOT PRODUCE SIGNIFICANT EFFECT ON MAGNESIUM AND POTASSIUM SERUM LEVEL OF CERVICAL CANCER PATIENTS RECEIVING CISPLATIN CHEMOTHERAPY

  2014cites this paper
• Histological Study of Toxic Effects of Cisplatin Single Dose Injection on Rat Kidney

  2014cites this paper
• Protective Effect of Forced Hydration on Cisplatin Nephrotoxicity

  2014cites this paper
• Protective Effect of Forced Hydration with Isotonic Saline, Potassium Chloride and Magnesium Sulfate on Cisplatin Nephrotoxicity: An Initial Evaluation

  2013cites this paper
• An update on the importance of monitoring serum magnesium in advanced disease patients

  2013cites this paper